Data Dictionary


Data Dictionary
Code Display Definition
no Not accumulated No contrast accumulated
less10-13 Less Than 10-30HU Less Than 10-30HU of contrast accumulated
more30 More Than 30HU More Than 30HU of contrast accumulated
Code Display Definition
upper Upper Lobus Affect localized in Upper Lobus
upperAndMedium Upper and Medium Lobbi Affect localized in Upper and Medium Lobbi
upperAndLower Upper and Lower Lobbi Affect localized in Upper and Lower Lobbi
medium Medium Lobus Affect localized in Medium Lobus
lower Lower Lobus Affect localized in Lower Lobus
mediumAndLower Medium and Lower Lobbi Affect localized in Medium and Lower Lobbi
total Total lung affected Total lung affected
Code Display Definition
Glukoza Glucose (mmol/l) Observation blood glucose (mmol/l)
GlukozaDiabetic Glucose: Diabetic Post-Meal (mmol/l) Observation of Glucose: Diabetic Post-Meal (mmol/l)
Total Protein Total Protein (g/l) Observation of total amount of protein in the blood (g/l)
Albumin Albumin (g/l) Observation of albumin to test liver function (g/l)
Urea Urea (mmol/l) Observation of Urea to test kidney fuction (mmol/l)
Kreatinini Creatinine (µmol/l) Observation of Creatinine to test kidney function (µmol/l)
HBsAg Hepatitis B Surface Antigen Protein test on the surface of Hepatitis B to detect infection
HCV Hepatitis C Virus Observation of Hepatitis C virus presence
Na+ Sodium (mmol/l) Observation of sodium in the blood (mmol/l)
Ca 2+ Calcium (mmol/l) Observation of calcium in the blood (mmol/l)
K+ Potassium (mmol/l) Observation of potassium in the blood (mmol/l)
ALP Alkaline phosphatase (u/l) Observation of alkaline phosphatase enzyme to test for liver disease or bone disorder (u/l)
GGT Gamma-Glutamyl Transpeptidase (u/l) Observation of gamma-glutamyl enzyme in the blood, mostly found in liver (u/l)
AST Aspartate Aminotransferase (u/l) Observation of Aspartate Aminotransferase enzyme (u/l)
ALT Alanine Aminotransferase (u/l) Observation of Alanine Aminotransferase enzyme found in liver and kidney, potentially even heart and muscles (u/l)
Total Bilirubin Total Bilirubin (µmol/l) Blood test to measure the amount of bilirubin (µmol/l)
ADA Adenosine Deaminase (u/l) Observation of Adenosine Deaminase enzyme (u/l)
APTT Activated Partial Thromboplastin Time (seconds) Screening test to evaluate the body's ability to form blood clot (seconds)
TT Thrombin Time (seconds) Measure of time it takes for a clot to form in plasma of a blood sample after thrombin has been added (seconds)
Pt Prothrombin Time (%) Measure to evaluate blood clotting time (%)
INR International Normalized Ratio Measure used to determine if blood is clotting as expected
Lipaza Lipase (u/l) Test for lipase pancreatic enzyme (u/l)
TSH Thyroid Stimulating Hormone (miu/l) Measure of how much thyroid-stimulating hormore is in blood (miu/l)
FT4 Free Thyroxine (ng/dl) Test used to determine thyroid function (ng/dl)
TT4 Total Thyroxine (mcg/dl) Observation of Total Thyroxine in the blood (mcg/dl)
ESR Erythrocyte Sedimentation Rate (mm/hr) Test to determine speed that erythrocytes settle to reveal inflammatory actvity (mm/hr)
CRP C-Reactive Protein (mg/l) Measure of c-reactive protein in blood, the protein that is associated with bodily inflammation (mg/l)
Hb Hemoglobin (g/l) Measure of hemoglobin in blood, the protein in red blood cells that carries oxygen from the lungs to the body (g/l)
HbA1c Hemoglobin A1c (%) Measure of the average blood sugar levels over 2-3 months (%)
FBS Fasting Blood Sugar (Glucose) (mmol/l) Measure of blood sugar after overnight fast (mmol/l)
TC Total Cholesterol (mmol/l) Measure of the total amount of each type of cholesterol in the blood (mmol/l)
Total WBC Total White Blood Cell count (x 10^9/l) Measure of white blood cells in blood or urine (x 10^9/l)
ANC Absolute Neutrophil Count (cells/µl) Measure of the number of neutrophils in the blood that kill bacteria (cells/µl)
ALC Absolute Lymphocyte Count (cells/µl) Measure of the level of lymphocyte (white blood cell) in blood (cells/µl)
AEC Absolute Eosinophil Count (cells/µl) Measure of the eosinophil, a type of white blood cell, in the blood (cells/µl)
NLR Neutrophil-lymphocyte ratio The number of neutrophils divided by the number of lymphocytes
Code Display Definition
hiv HIV HIV/AIDS (Human immunodeficiency virus / Acquired immunodeficiency syndrome)
diabets Diabetes The simultaneous presence of TB and diabetes, a disease where the patient's ability to produce or response to insulin is impaired causing an abnormal metabliosm of carbohydrates and increased measures of glucose in blood and urine
hepaticDiseases Hepatic diseases The simultaneous presence of TB and any liver disease that damanfes the liver and prevents normal functioning
hepatitisB Hepatitis B The simultaneous presence of TB and the Hepatitis B virus, a severe virus that causes liver infection
hepatitisC Hepatitis C The simultaneous presence of TB and the Hepatitis C virus which attacks and inflames the liver
renalDisease Renal disease The simultaneous presence of TB and Renal diseases (chronic kidney disease) in which the kidney losed function causing impairment and damage to kidney
anemia Anemia The simultaneous presence of TB and anemia, a deficiency of red blood cells or hemoglobin leading to reduced oxygern flow to the body's organs
none None No comorbidities
notSpecified Not specified Comorbidity not specified
others Others Other comorbidities (not listed)
COVID_19 COVID-19 The simultaneous presence of TB and the repiratory virus that casues coronavirus disease 19 (COVID-19)
Post-COVID-19 Post-COVID-19 Post-COVID-19
pneumoconiosis Pneumoconiosis The simultaneous presence of TB and pneumoconiosis; a disease of the lungs due to inhalation of dust, characterized by inflammation, coughing, and fibrosis
corticosteroids Systemically administered glucocorticoids, cytostatics, TNF-α antagonists The simultaneous presence of TB and systemically administered glucocorticoids, cytostatics, TNF-α antagonists
psychiatric Psychiatric illness The simultaneous presence of TB and mental and behavioural disorders
Code Display Definition
no Not used Contrast not used
0407-1413-10 OMNIPAQUE 350 OMNIPAQUE 350 is used as contrast
Code Display Definition
liquid Liquid Liquid
solid Solid Solid
notSpecified Not specified Not specified
Code Display Definition
good Good image quality Good image quality
average Average image quality Average image quality
poor Poor image quality Poor image quality
Code Display Definition
new New New patients have never been treated for TB or have taken anti-TB drugs for less than 1 month
relapse Relapse Relapse patients have previously been treated for TB, were declared cured or treatment completed at the end of the most recent course of treatment, and are now diagnosed with a recurrent episode of TB (either a true relapse or a new episode of TB caused by reinfection)
ltfu Lost to follow up Treatment after loss to follow-up patients have previously been treated for TB and were declared lost to follow-up at the end of their most recent course of treatment. (These were previously known as treatment after default patients.)
failure Failure Treatment after failure patients are those who have previously been treated for TB and whose treatment failed at the end of the most recent course of treatment
other Other Other previously treated patients are those who have previously been treated for TB but whose outcome after the most recent course of treatment is unknown or undocumented
unknown Unknown Unknown case definition
chronic Chronic TB Chronic TB is diagnosed in patients who don’t have clinical and radiological stabilization of the process or the process worsens clinically or radiologically (the presence of cavities either with or without sputum conversion within 2 years)
Code Display Definition
H Isoniazid Isoniazid (H, INH)
R Rifampicin Rifampicin (R, RIF)
S Streptomycin Streptomycin (S)
E Ethambutol Ethambutol (E, EMB)
Ofx Ofloxacin Ofloxacin (Ofx)
Cm Capreomycin Capreomycin (Cm)
Am Amikacin Amikacin (Am)
Km Kanamycin Kanamycin (Km)
Z Pyrazinamide Pyrazinamide (Z, PZA)
Lfx Levofloxacin Levofloxacin (Lfx)
Mfx Moxifloxacin Moxifloxacin (Mfx)
Mfx 0.25 Moxifloxacin 0.25 Moxifloxacin 0.25 (Mfx 0.25)
Mfx 0.5 Moxifloxacin 0.5 Moxifloxacin 0.5 (Mfx 0.5)
Mfx 1.0 Moxifloxacin 1.0 Moxifloxacin 1.0 (Mfx 1.0)
Mfx 2.0 Moxifloxacin 2.0 Moxifloxacin 2.0 (Mfx 2.0)
Pas p-aminosalicylic acid p-aminosalicylic acid (Pas, PAS)
Pto Prothionamide Prothionamide (Pto)
Cs Cycloserine Cycloserine (Cs)
Amx/Clv Amoxicillin-clavulanate Amoxicillin-clavulanate (Amx/Clv)
Mb Mycobutin Mycobutin (Mb)
Eto Ethionamide Ethionamide (Eto)
Dld Delamanid Delamanid (Dlm)
Bdq Bedaquiline Bedaquiline (Bdq)
Ipm/Cln Imipenem-cilastatin Imipenem-cilastatin (Ipm/Cln)
Lzd Linezolid Linezolid (Lzd)
Cfz Clofazimine Clofazimine (Cfz)
Clr Clarithromycin Clarithromycin (Clr)
Ft Fluoroquinolones Fluoroquinolones (Ofx, Lfx or Mfx )
AG/CP Aminoglycosides - injectible agents Aminoglycosides - injectible agents (Cm, Km, Am)
Gfx Gatifloxacin Gatifloxacin (Gfx)
Gfx 0.5 Gatifloxacin 0.5 Gatifloxacin 0.5 (Gfx 0.5)
CPFX Ciprofloxacin Ciprofloxacin (CPFX). A broad spectrum fluoroquinolone antibiotic
Code Display Definition
MDRnonXDR MDR non XDR Multidrug resistance: resistance to at least both isoniazid and rifampicin
monoDR Mono DR Monoresistance: resistance to one first-line anti-TB drug only
polyDR Poly DR Polydrug resistance: resistance to more than one first-line anti-TB drug (other than both isoniazid and rifampicin)
sensitive Sensitive No resistance to TB drugs
preXDR Pre-XDR TB caused by Mycobacterium tuberculosis (M. tuberculosis) strains that fulfil the definition of multidrug resistant and rifampicin-resistant TB (MDR/RR-TB) and which are also resistant to any fluoroquinolone
XDR XDR TB caused by Mycobacterium tuberculosis (M. tuberculosis) strains that fulfil the definition of MDR/RR-TB and which are also resistant to any fluoroquinolone and at least one additional Group A drug. (Group A drugs are the most potent group of drugs in the ranking of second-line medicines for the treatment of drug-resistant forms of TB using longer treatment regimens and comprise (levofloxacin, moxifloxacin, bedaquiline and linezolid)
negative Negative Negative
Code Display Definition
bactec Bactec Determination of drug susceptibility testing of Mycobacterium in an automated system BACTEC MGIT 960
hain FL-LPA Line-Probe Assay (LPA) test other than Hain
lpaOther SL-LPA Line-Probe Assay (LPA) test systems for Hain Lifescience molecular genetic diagnosis of mycobacteria, based on a unique DNA • Strip® technology (hybridization with DNA probes (MLPA))
le Lowenstein-Jensen Solid medium Lowenstein - Jensen containing drug concentration
genexpert GeneXpert Xpert MTB / RIF test to carry out the detection of the presence of Mycobacterium tuberculosis in a sample of diagnostic material and resistance to rifampicin in less than two hours
truenat TRUENAT A Chip-based Real Time PCR test that is considered as an alternative for Gene-Xpert, a CBNAAT (cartridge based nucleic acid amplification test) test in resource limited settings
dst DST Drug-susceptibility test performed to determine resistance or sensitivity to tuberculosis drugs
Code Display Definition
employed Employed Official work/position
retired Retired Retirement age (not working)
student Student Higher or secondary education in progress
unemployed Unemployed No official work/position
disabled Disabled Disability for medical reasons
selfEmployed Self-employed Self-employed
homemaker Homemaker Homemaker
unofficiallyEmployed Unofficially employed Unofficially employed
Code Display Definition
less10mm Less than 10mm Lung cavity size less than 10mm
10-25mm 10-25mm Lung cavity size less than 10-25mm
more25mm More than 25mm Lung cavity size more than 25mm
no No cavities No lung cavity
Code Display Definition
zn Ziehl-Neelsen Bacteriological stain used to identify acid-fast organisms, mainly Mycobacteria
florescence Fluorescence Fluorescent microscopy used to image specific features of small specimens
notSpecified Not Specified Microscopy type not specified
Code Display Definition
rightLung Right lung Affect localized in right lung
leftLung Left lung Affect localized in left lung
both Both lungs Affect localized in both lungs
Code Display Definition
stillOnTreatment Still on treatment A patient who is still undergoing treatment
died Died A patient who dies for any reason during the course of treatment
cured Cured Treatment completed as recommended by the national policy without evidence of failure AND three or more consecutive cultures taken at least 30 days apart are negative after the intensive phase
completed Completed Treatment completed as recommended by the national policy without evidence of failure BUT no record that three or more consecutive cultures taken at least 30 days apart are negative after the intensive phase
ltfu Lost to follow up Treatment after loss to follow-up patients have previously been treated for TB and were declared lost to follow-up at the end of their most recent course of treatment. (These were previously known as treatment after default patients.)
unknown Unknown A patient for whom no treatment outcome is assigned. (This includes cases transferred out to another treatment unit and whose treatment outcome is unknown)
failure Failure Treatment terminated or need for permanent regimen change of at least two anti - TB drugs because of: a lack of conversion by the end of the intensive phase, or a bacteriological reversion in the continuation phase after conversion to negative, or a evidence of additional acquired resistance to fluoroquinolones or second - line injectable drugs, or a adverse drug reactions (ADRs)
palliativeCare Palliative Care An approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial, and spiritual
Code Display Definition
H Isoniazid Isoniazid (H, INH)
R Rifampicin Rifampicin (R, RIF)
S Streptomycin Streptomycin (S)
E Ethambutol Ethambutol (E, EMB)
Ofx Ofloxacin Ofloxacin (Ofx)
Cm Capreomycin Capreomycin (Cm)
Am Amikacin Amikacin (Am)
Km Kanamycin Kanamycin (Km)
Z Pyrazinamide Pyrazinamide (Z, PZA)
Lfx Levofloxacin Levofloxacin (Lfx)
Mfx Moxifloxacin Moxifloxacin (Mfx)
Pas p-aminosalicylic acid p-aminosalicylic acid (Pas)
Pto Prothionamide Prothionamide (Pto)
Cs Cycloserine Cycloserine (Cs)
Amx/Clv Amoxicillin-clavulanate Amoxicillin-clavulanate (Amx/Clv)
Mb Mycobutin Mycobutin (Mb)
Eto Ethionamide Ethionamide (Eto)
Dld Delamanid Delamanid (Dlm)
Bdq Bedaquiline Bedaquiline (Bdq)
Ipm/Cln Imipenem-cilastatin Imipenem-cilastatin (Ipm/Cln)
Lzd Linezolid Linezolid (Lzd)
Cfz Clofazimine Clofazimine (Cfz)
Clr Clarithromycin Clarithromycin (Clr)
Ft Fluoroquinolones Fluoroquinolones (Fq)
AG/CP Aminoglycosides - injectible agents Aminoglycosides - injectible agents (Cm, Km, Am)
Trd Terizidone Terizidone (Trd)
Pa Pretomanid Pretomanid (Pa)
ART Antiretroviral therapy Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs
Cotrimoxazol Cotrimoxazol preventive Co-trimoxazole preventive therapy (CPT)
Gfx Gatifloxacin Gatifloxacin (Gfx)
Gfx 0.5 Gatifloxacin 0.5 Gatifloxacin 0.5 (Gfx 0.5)
Code Display Definition
focal Nodule less than 10mm Nodule less than 10mm
focus Node more than 10mm Node more than 10mm
focalFocus Nodule and node Both Nodule <10mm and Node >10mm
infiltrate Infiltrate(s) Localised alveoloacinar diseases
focalFocusInfiltrate Nodule, node and infiltrate Nodule <10mm, Node >10mm and Infiltrate together
Code Display Definition
family Family and household Defined as people living in the same household as the index patient, or as relatives of the index patient and are spending many hours a day together with the patient in the same indoor space
prof Professional Defined as people spending many hours a day together with the patient in the same professional indoor space
hospital Nosocomial Defined as originating in a hospital
prison Penitential, pre-trial detention facilities Defined as people living in the same detention facility as the index patient
military Military services Defined as relating to contact of soldiers or armed forces
other Other Other
Code Display Definition
1 1 cavity One lung cavity
2 2 cavities Two lung cavities
more3 More than 2 cavities More than two cavities
no No cavities No cavities
Code Display Definition
male Male Male
female Female Female
other Other Other
unknown Unknown Unknown
Code Display Definition
S1 S1 Affected segment S1
S1+2 S1+2 Affected segment S1 + 2
S1-3 S1-3 Affected segment S1-3
S2 S2 Affected segment S2
S2+3 S2+3 Affected segment S2 + 3
S3 S3 Affected segment S3
S4 S4 Affected segment S4
S5 S5 Affected segment S5
S4+5 S4+5 Affected segment S4 - 5
S1-5 S1-5 Affected segment S1-5
S6 S6 Affected segment S6
S1-6 S1-6 Affected segment S1-6
S7-10 S7-10 Affected segment S7-10
Total All segments Affected all segments
Code Display Definition
biopsy Biopsy Biopsy sample for TB diagnostic is used
sputum Sputum Sputum sample for TB diagnostic is used
other Other Other sample for TB diagnostic is used
surgeryCaseousMasses Surgery-caseous masses Masses which are in a cavity or in other TB lesions of lungs (tuberculoma, large nodi or conglomerate of the nodi)
surgeryCavityInternalWall Surgery-cavity internal wall Internal wall of a cavity
surgeryCavityExternalWall Surgery-cavity external wall External wall of a cavity
surgeryModulu Surgery-infectious granuloma Infectious granulomas (which are formed by cells as a reaction to a tuberculosis infection)
surgeryHealthy tissue Surgery-healthy tissue The lung tissue not damaged by tubercular process
bronchialLavage Bronchial lavage The liquid received at a bronchial lavage during a bronchoscopy
asciticFluid Ascitic fluid Liquid gathered in an abdominal cavity at various pathological states
blood Blood Blood
urine Urine Urine
pleuralFluid Pleural fluid Pleural fluid
cerebrospinalFluid Cerebrospinal Fluid An ultrafiltrate of plasma contained within the ventricles of the brain and the subarachnoid spaces of the cranium and spine
paraffinEmbeddedTissue Paraffin Embedded Tissue A standard technique used in clinical and research laboratories to create a formalin-fixed, paraffin-embedded block of tissue
Code Display Definition
preliminary Preliminary This is a preliminary composition or document (also known as initial or interim). The content may be incomplete or unverified
final Final This version of the composition is complete and verified by an appropriate person and no further work is planned. Any subsequent updates would be on a new version of the composition
amended Amended The composition content or the referenced resources have been modified (edited or added to) subsequent to being released as "final" and the composition is complete and verified by an authorized person
retracted Retracted The composition was originally created/issued in error and this is an amendment that marks that the entire composition and any past versions or copies should not be considered as valid
Code Display Definition
singleColony 1 to 19 1 to 19 colonies (Single Colony)
1+ 20 to 100 20 to 100 colonies (1+)
2+ 100 to 200 100 to 200 colonies (2+)
3+ More than 200 More than 200 colonies (3+)
positive Positive Growth of mycobacterium (Positive)
negative Negative At the end of the study protocol growth is not fixed (Negative)
unknownData Unknown result Result not entered
unfinishedResult Study in progress Continuing the study (in progress)
notDone Not done Not done
contamination Nonspecific microflora The appearance of nonspecific microflora growth alone or together with mycobacteria
mott MOTT Mycobacterium other than tuberculosis (MOTT)
Code Display Definition
upperLeft Upper Left Sextant Upper Left Sextant
upperRight Upper Right Sextant Upper Right Sextant
midLeft Middle Left Sextant Middle Left Sextant
midRight Middle Right Sextant Middle Right Sextant
lowerLeft Lower Left Sextant Lower Left Sextant
lowerRight Lower Right Sextant Lower Right Sextant
Code Display Definition
practitioner General practitioner General practitioner
radiologist Radiologist Radiologist
other Other Other
Code Display Definition
A15 A15 A15 - Respiratory tuberculosis, bacteriologically and histologically confirmed
A15.0 A15.0 A15.0 - Tuberculosis of lung, confirmed by sputum microscopy with or without culture
A15.1 A15.1 A15.1 - Tuberculosis of lung, confirmed by culture only
A15.2 A15.2 A15.2 - Tuberculosis of lung, confirmed histologically
A15.3 A15.3 A15.3 - Tuberculosis of lung, confirmed by unspecified means
A15.4 A15.4 A15.4 - Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically
A15.5 A15.5 A15.5 - Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically
A15.6 A15.6 A15.6 - Tuberculous pleurisy, confirmed bacteriologically and histologically
A15.7 A15.7 A15.7 - Primary respiratory tuberculosis, confirmed bacteriologically and histologically
A15.8 A15.8 A15.8 - Other respiratory tuberculosis, confirmed bacteriologically and histologically
A15.9 A15.9 A15.9 - Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
A16 A16 A16 - Respiratory tuberculosis, not confirmed bacteriologically or histologically
A16.0 A16.0 A16.0 - Tuberculosis of lung, bacteriologically and histologically negative
A16.1 A16.1 A16.1 - Tuberculosis of lung, bacteriological and histological examination not done
A16.2 A16.2 A16.2 - Tuberculosis of lung, without mention of bacteriological or histological confirmation
A16.3 A16.3 A16.3 - Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation
A16.4 A16.4 A16.4 - Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation
A16.5 A16.5 A16.5 - Tuberculous pleurisy, without mention of bacteriological or histological confirmation
A16.7 A16.7 A16.7 - Primary respiratory tuberculosis without mention of bacteriological or histological confirmation
A16.8 A16.8 A16.8 - Other respiratory tuberculosis, without mention of bacteriological or histological confirmation
A16.9 A16.9 A16.9 - Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation
A17 A17 A17 - Tuberculosis of nervous system
A17.0 A17.0 A17.0 - Tuberculous meningitis
A17.1 A17.1 A17.1 - Meningeal tuberculoma
A17.8 A17.8 A17.8 - Other tuberculosis of nervous system
A17.9 A17.9 A17.9 - Tuberculosis of nervous system, unspecified
A18 A18 A18 - Tuberculosis of other organs
A18.0 A18.0 A18.0 - Tuberculosis of bones and joints
A18.1 A18.1 A18.1 - Tuberculosis of genitourinary system
A18.2 A18.2 A18.2 - Tuberculous peripheral lymphadenopathy
A18.3 A18.3 A18.3 - Tuberculosis of intestines, peritoneum and mesenteric glands
A18.4 A18.4 A18.4 - Tuberculosis of skin and subcutaneous tissue
A18.5 A18.5 A18.5 - Tuberculosis of eye
A18.6 A18.6 A18.6 - Tuberculosis of ear
A18.7 A18.7 A18.7 - Tuberculosis of adrenal glands
A18.8 A18.8 A18.8 - Tuberculosis of other specified organs
A19 A19 A19 - Miliary tuberculosis
A19.0 A19.0 A19.0 - Acute miliary tuberculosis of a single specified site
A19.1 A19.1 A19.1 - Acute miliary tuberculosis of multiple sites
A19.2 A19.2 A19.2 - Acute miliary tuberculosis, unspecified
A19.8 A19.8 A19.8 - Other miliary tuberculosis
A19.9 A19.9 A19.9 - Miliary tuberculosis, unspecified
U84.3 U84.3 U84.3 - Resistance to tuberculostatic drug(s)
unknown Unknown Unknown diagnosis
Code Display Definition
clinicalOpinion Clinically diagnosed Clinically diagnosed
positiveTB Positive TB Positive TB
Code Display Definition
R R (Resistant) In a population of more than 1% of resistant mycobacteria, i.e. growth 20 CE medium with an abundant growth in control
S S (Sensitive) In a population of less than 1% of resistant mycobacteria, i.e. growth 20 CE medium with an abundant growth in control
I I (Intermediate) Result not determined
Code Display Definition
basicSchool Basic school (incl. primary) Basic scool: providing instruction in reading, writing and mathematics; the formation of ideas about man and the world, labor skills
completeSchool Complete school (a-level, gymnasium) Complete scool: aimed at preparing him for a full life in society, students master the fundamentals of science, the state languages of the Republic of Belarus, skills, mental and physical labor, ready to begin work and further education
college College (bachelor) College: aimed at the development of the individual student, trainee, they receive a special theoretical and practical training, culminating in qualification specialists with secondary special education, working with secondary special education
higher Higher (university) Higher Education: to provide a special theoretical and practical training, culminating in qualification of specialists with higher education, a master's degree
noEducation No education No education, or basic scool in progress
Code Display Definition
pulm Pulmonary Pulmonary tuberculosis (PTB) refers to any bacteriologically confirmed or clinically diagnosed case of TB involving the lung parenchyma or the tracheobronchial tree. Miliary TB is classified as PTB because there are lesions in the lungs. Tuberculous intra - thoracic lymphadenopathy(mediastinal and / or hilar) or tuberculous pleural effusion, without radiographic abnormalities in the lungs, constitutes a case of extrapulmonary TB
extraPulm Extrapulmonary Extrapulmonary tuberculosis (EPTB) refers to any bacteriologically confirmed or clinically diagnosed case of TB involving organs other than the lungs, e.g. pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and bones, meninges
both Pulmonary and Extrapulmonary Pulmonary tuberculosis(PTB) and extrapulmonary TB(EPTB) diagnosed at the same time
unknown Unknown Unknown
Code Display Definition
-0.09 1 to 9 in 100 (1-9/100) 1 to 9 acid-resistant bacteria in 100 fields of view (1-9/100)
1+ 10 to 99 in 100 (1+) 10 to 99 acid-resistant bacteria in 100 fields of view (1+)
2+ 1 to 9 in 1 (2+) 1 to 9 acid-resistant bacteria in 1 fields of view (2+)
3+ 10 to 99 in 1 (3+) 10 to 99 acid-resistant bacteria in 1 fields of view (3+)
4+ More than 99 in 1 (4+) All fields of view (4+)
saliva Saliva Saliva sample for the study is not suitable
unknownData Unknown data No data
negative Negative Negative result
notDone Not done Not done
Code Display Definition
CR CR (Computed Radiography) CR (Computed Radiography)
CT CT (Computed Tomography) CT (Computed Tomography)
XC XC (External-camera Photography) XC (External-camera Photography)
XA XA (X-Ray Angiography) XA (X-Ray Angiography)
HC HC (Hard Copy) HC (Hard Copy)
DX DX (Digital X-ray) DX (Digital X-ray)
Code Display Definition
neg Negative
pos Positive
Code Display Definition
less2 Less than 2 segments Prevalence of process in less than 2 segments
more2 2 or more segments Prevalence of process in more than or equal to 2 segments
Code Display Definition
homeless Homeless Patient does not have a permanent place of residence and / or registration
exPrisoner Ex prisoner The patient was imprisoned in the past
travelOutOfWork Worked abroad Country citizen, spent some time working abroad
tbFacility TB care worker Patient works in the health system (TB facility or general healthcare)
tobacoUse Current smoker Current smoker
drugAbuse Patient drug abuse Patient drug abuse
alcoholism Patient alcohol abuse Patient alcohol abuse
ContactOfKnownMdrTbCase Documented MDR contact Contact with MDR was investigated and documented
immigrant Immigrants, refugees, internal migrants Immigrants, refugees, internal migrants
alcoholUnknown Patient alcohol abuse not available/unknown Patient alcohol abuse data not available, or is unknown
smokingUnknown Patient smoking data not available/unknown Patient smoking data is not available, or is unknown
Code Display Definition
pleurisy Exudative pleurisy Exudative pleurisy
cardiopulmonaryInsufficiency Cardiopulmonary insufficiency Cardiopulmonary insufficiency
pneumothorax Pneumothorax Pneumothorax
bloodSpitting Blood spitting Blood spitting
lulmonaryHemorrhage Pulmonary hemorrhage Pulmonary hemorrhage
amyloidosis Amyloidosis Amyloidosis
other Other Other
noComplications No complications No complications
Code Display Definition
H Isoniazid Isoniazid (H, INH)
R Rifampicin Rifampicin (R, RIF)
S Streptomycin Streptomycin (S)
E Ethambutol Ethambutol (E, EMB)
Ofx Ofloxacin Ofloxacin (Ofx)
Cm Capreomycin Capreomycin (Cm)
Am Amikacin Amikacin (Am)
Km Kanamycin Kanamycin (Km)
Z Pyrazinamide Pyrazinamide (Z, PZA)
Lfx Levofloxacin Levofloxacin (Lfx)
Mfx Moxifloxacin Moxifloxacin (Mfx)
Pas p-aminosalicylic acid p-aminosalicylic acid (Pas, PAS)
Cs Cycloserine Cycloserine (Cs)
Eto Ethionamide Ethionamide (Eto)
Dld Delamanid Delamanid (Dlm)
Bdq Bedaquiline Bedaquiline (Bdq)
Lzd Linezolid Linezolid (Lzd)
Cfz Clofazimine Clofazimine (Cfz)
Ft Fluoroquinolones Fluoroquinolones (Ofx, Lfx or Mfx )
AG/CP Aminoglycosides - injectible agents Aminoglycosides - injectible agents (Cm, Km, Am)
CPFX Ciprofloxacin Ciprofloxacin (CPFX). A broad spectrum fluoroquinolone antibiotic
Code Display Definition
ended Treatment ended Treatment ended (for current treatment regimen)
adverse Adverse event Adverse event documented (treatment stopped for current treatment regimen)
resistance Treatment ineffective due to additional resistance Additional resistance discovered, treatment regimen is not effctive (treatment stopped for current treatment regimen)
continuation Continuation of treatment Continuation of treatment (for current treatment regimen)
newDrugAvailable New drugs available New drugs available (for current treatment regimen)
patientStoppedTreatment Patient stopped treatment Patient stopped treatment (for current treatment regimen)
terminated Terminated from study Terminated from study (for current treatment regimen)
notAvailable Drug(s) no longer available Drug(s) no longer available (for current treatment regimen)
Field Descriptions Grouped by Data Type
Field Name Description
Age of Onset Age of onset of tuberculosis (e.g. 40)
Height Length of body in centimeters
Weight Relative mass of body in kilograms
Body Mass Index (BMI) A person's weight in kilograms divided by the square height in meters
Field Name Description
Culture Test to determine presence of bacteria that cause tuberculosis and other infections caused by similar bacteria
Date: Culture Date of culture first growth
Field Name Description
Genome Set of genes used for DNA sequencing
Lineage Classification determined by spoligotype using the lorikeet spoligotype analysis software (e.g. Beijing)
NCBI BioProject Record identifier assigned by NCBI for entry in the BioProject database (e.g. PRJNA229571)
NCBI BioSample Record identifier assigned by NCBI for entry in the BioSample database (e.g. SAMN02419534)
NCBI Source Organism Record identifier for Mycobacterium tuberculosis organism sample in the NCBI SRA database (e.g. 22083)
NCBI SRA Record identifier assigned by NCBI for entry in the SRA database (e.g. SRR1159723)
Octal spoligotype Octal spoligotype determined by the lorikeet spoligotype analysis software (e.g. 000000000003731)
Field Name Description
Affect Pleura Changes in the pleura
Anomaly of lung develop Anomaly of lung develop detected (yes or no)
Anomaly Of Mediastinum Vessels Develop Anomaly Of Mediastinum Vessels Develop detected (yes or no)
Dissemination Diffuse pulmonary nodules detected (yes or no)
Field Name Description
Organization The study site where patient case is managed
Patient Local Identifier Private identifier used by data entry specialists to map patient information to a patient case
Field Name Description
Number of Children Number of Children (e.g. 2)
Number of Daily Contacts Total number of close contacts, defined as people living in the same household as the index patient, or spending many hours a day together with the patient in the same indoor space (e.g. 2)
Field Name Description
Date: Bone Marrow Collection Date of bone marrow collection
Date: Mesenchymal Stromal/Stem Cells Re-Infusion Date of mesenchymal stromal/stem cells re-infusion
Cell Dose Cell dose
Field Name Description
Transcriptomics Study data of transcriptomes and their functions
Field Name Description
Biochemistry Measure of amount or activity of a particular enzymne or protein in a blood or urine sampe
Date: Biochemistry Date biochemsitry test results are ready
Field Name Description
Drug Susceptibility Testing Test to determine a patients sensitivity to tuberculosis drugs
Date: DST Date drug suspectablity test result is ready
SNP Single nucleotide polymorphism as provided in reference sequence annotation (e.g. gyrA-D94G-HighConfidence)
SNP Mutations Single Nucleotide Polymorphism detected at one nucleotide due to mutation at that precise nucleotide
Wild type probes Gene that prevails in a natural population of organisms or strain of organisms in contrast to natural or labortory mutant forms
Mutation probes Mutation probes found in LPA
Field Name Description
Imaging: Study Date Date image was taken
Field Name Description
Microscopy Microscopic invesitgation of specimen sample
Date: Microscopy Date Microscopy result is ready for review
Field Name Description
Regimen A prescribed course of medical treatment for the promotion or restoration of health
Field Name Description
Specimen Sample of material used for medical testing
Specimen Local Identifier Private identifer assigned to specimen designated by user
Public Identifier: Specimen Public identifer automatically assigned to specimen
Date Collected: Specimen Date specimen sample collection was performed
Field Name Description
TB Profiler This data is for research purposes only. Please visit https://tbdr.lshtm.ac.uk/ to access the TB Profiler. The "READ ME" can be found by visiting https://github.com/jodyphelan/TBProfiler#readme
main_lineage Categorization of the TB bacteria into one of the seven well-defined and widely recognized groups of TB bacteria
sub_lineage A subcategorization of the TB bacteria nested within the main lineage
main_lineage and sub_lineage Determined by a well-defined set of genomic SNPs
Num. Drug Resistant Variants The total number of drug resistant variants predicted by TB Profiler
TB Profiler Resistance Prediction The predicted TB resistance profile based on the TB Profiler tool
Field Name Description
Treatment The management and care of a patient to combat disease
Date: Treatment Start Date treatment began
Date: Treatment End Date treatment ended
Outcome Change in the health of an individual, group of people, or population that is attributable to an intervention or series of interventions